|
|
||||||||
Investigative Ophthalmology & Visual Science, Vol 24, 1426-1429, Copyright © 1983 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
M Jacobson, YR Sharma, E Cotlier and JD Hollander
Sorbitol, resulting from glucose metabolism through aldose reductase, may play a role in diabetic complications such as cataracts, neuropathy, and vasculopathy. Sulindac (Clinoril) and sorbinil, two inhibitors of aldose reductase, decreased sorbitol formation in cataract or nerve tissue incubated in high glucose TC-199 media. Sulindac, a widely used anti-rheumatic drug, may have clinical applications in preventing diabetic complications.
This article has been cited by other articles:
![]() |
R. N. Harden Complex regional pain syndrome Br. J. Anaesth., July 1, 2001; 87(1): 99 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Williams and J. Odom Study of aldose reductase inhibition in intact lenses by 13C nuclear magnetic resonance spectroscopy Science, July 11, 1986; 233(4760): 223 - 225. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |